Back
Rapport Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
RAPP
Rapport Therapeutics, Inc.
Last Price:
$30.17
Seasonality Move:
-47.31%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPP is experiencing slight buying pressure.
Rapport Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Sell |
| 20-day SMA: | 29.55 | Buy |
| 50-day SMA: | 27.66 | Buy |
| 200-day SMA: | 18.05 | Buy |
| 8-day EMA: | 25.3 | Buy |
| 20-day EMA: | 15.36 | Buy |
| 50-day EMA: | 7.43 | Buy |
| 200-day EMA: | 2.06 | Buy |
Rapport Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.36 | Buy |
| Relative Strength Index (14 RSI): | 54.61 | Buy |
| Chaikin Money Flow: | 84937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28 - 30.52) | Buy |
| Bollinger Bands (100): | (19.27 - 29.97) | Buy |
Rapport Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapport Therapeutics, Inc. Stock
Is Rapport Therapeutics, Inc. Stock a Buy?
-
Rapport Therapeutics, Inc. share price is 30.20 while RAPP 8-day simple moving average is 30.45, which is a Sell signal.
-
The stock price of RAPP is 30.20 while Rapport Therapeutics, Inc. 20-day SMA is 29.55, which makes it a Buy.
-
Rapport Therapeutics, Inc. 50-day simple moving average is 27.66 while RAPP share price is 30.20, making it a Buy technically.
-
RAPP stock price is 30.20 and Rapport Therapeutics, Inc. 200-day simple moving average is 18.05, creating a Buy signal.
RAPP Technical Analysis vs Fundamental Analysis
Sell
26
Rapport Therapeutics, Inc. (RAPP)
is a Sell
Is Rapport Therapeutics, Inc. a Buy or a Sell?
-
Rapport Therapeutics, Inc. stock is rated a SellThe current Rapport Therapeutics, Inc. [RAPP] share price is $30.20. The Score for RAPP is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Rapport Therapeutics, Inc. Stock Info
Market Cap:
1.1B
Price in USD:
30.20
Share Volume:
221.9K
Rapport Therapeutics, Inc. 52-Week Range
52-Week High:
42.27
52-Week Low:
6.43
Sell
26
Rapport Therapeutics, Inc. (RAPP)
is a Sell
Rapport Therapeutics, Inc. Share Price Forecast
-
What is the Rapport Therapeutics, Inc. stock price today?The Rapport Therapeutics, Inc. stock price is 30.20 USD today.
-
Will RAPP stock go up or go down?Rapport Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapport Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapport Therapeutics, Inc. is overvalued.
Is Rapport Therapeutics, Inc. Stock a Buy?
-
Rapport Therapeutics, Inc. share price is 30.20 while RAPP 8-day exponential moving average is 25.30, which is a Buy signal.
-
The stock price of RAPP is 30.20 while Rapport Therapeutics, Inc. 20-day EMA is 15.36, which makes it a Buy.
-
Rapport Therapeutics, Inc. 50-day exponential moving average is 7.43 while RAPP share price is 30.20, making it a Buy technically.
-
RAPP stock price is 30.20 and Rapport Therapeutics, Inc. 200-day simple moving average is 2.06, creating a Buy signal.
Fundamental Analysis of Rapport Therapeutics, Inc.
Is Rapport Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.14 per share, and a decrease next year of $0.61 per share.
Technical Analysis of Rapport Therapeutics, Inc.
Should I short Rapport Therapeutics, Inc. stock?
-
RAPP Moving Average Covergence Divergence (MACD) indicator is 8.36, suggesting Rapport Therapeutics, Inc. is a Buy
-
Rapport Therapeutics, Inc. Relative Strength Index (RSI) is 54.61, which suggest Rapport Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapport Therapeutics, Inc. is (28 - 30.52), which suggest Rapport Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapport Therapeutics, Inc. is (19.27 - 29.97), which suggest Rapport Therapeutics, Inc. is a Buy
* Rapport Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.